FDA Investigator Latoya S Oliver Powell
Latoya S Oliver Powell has inspections in 2 countries as of 08 Sep 2023. Latoya S Oliver Powell has collaborated with a combined 1778 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
28
Last Inspection Date:
08 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland,
United States of America
Co-Investigator(s):
Adams,
Amanda B Athey,
Amanda M Osteen,
Andrew J Howard,
Brooke K Higgins,
Bruce C Kovak,
Cassandra K Johnson,
Charlean R Butler,
Charles E Idjagboro,
Chiang Syin, PhD,
Christine M O'leary,
Clarice J Ahn,
Conrad M Guardia,
Cynthia A Harris, MD, RN,
Daniel W Johnson,
David A Carlson,
David A Trent Carlson,
David P Rice,
Dawn M Collins,
Deyaa Shaheen,
Edette J Newby,
Edward P Potter,
Elizabeth A Laudig,
Elvis D Morton,
Emest F Bizjak,
Emmanuel A Dimaano, Jr,
Eric L Dong, BS,
Eric L Vangraafeiland,
Erin L Mcfiren,
Esaw,
Gale L Glinecki,
Gerald W Kopp,
Gifford Whitehurst, Jr,
Heath R Harley,
Jacqueline Johnson,
James W Leonette,
Jamie D Swann,
Jeffrey A Reed,
Jessica D Nanini,
Joanne S Wilson,
John Dan,
John M Gusto,
Johnson,
Joseph W Matthews,
Justin A Hefferman,
Katherine M Williams,
Kenneth L Smalls,
Latoya Oliver Powell,
Laurissa S Flowers,
LCDR Cornelius Brown, III,
LCDR Wilfred A Darang,
Lori S Lawless,
Marc A Jackson, Jr,
Margaret H Waters,
Marla A Cassidy,
Melissa J Garcia,
Michael D Ellison,
Michael S Call,
Mildred L Mccray,
Mohamad A Chahine,
Myra L Gemmill,
Natasha A Dezinna,
Nebil A Oumer,
Nicholas P Schaub,
Nina D Patel,
Normica G Facey,
Osama M Hamoud,
Patricia A Morrow,
Pelekakis,
Philip W Beck,
Pratik S Upadhyay, DDC,
Qiang Gui,
Qin Xu,
Rachael A Wiederock,
Rachel C Harrington,
Regina Gibson Melton,
Sean R Moynihan, MPH,
Sierra M Shockley,
Stacey A Priest,
State Agency,
Stephanie A Madison,
Stephen C Eason,
Steven P Donald,
Suzanne M Healy,
Suzanne M Muchene,
Tamara N Champion,
Tamika E Allen, RN,
Tammy M Phillips,
Tania E Vizcaino,
Teresa L Fox,
Theresa M Smedley,
Thomas,
Thomas J Hudson,
Upendra Paudel,
Valerie G Vallely,
Vincent T Duncan,
Wanda Y Honeyblue,
Wayne L Jefferson,
William D Murray,
Xiandong Meng,
Xiaohan Cai, PhD,
Yan Qin
Latoya S Oliver Powell's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2010 | FDA 483 | ChemPacific Corporation - Form 483, 2010-02-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more